Third Rock Ventures VI, L.P. - 11 Aug 2023 Form 3 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
Director
Signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP VI, LLC, general partner of Third Rock Ventures GP VI, L.P., general partner of Third Rock Ventures VI, L.P.
Issuer symbol
TNGX
Transactions as of
11 Aug 2023
Net transactions value
$0
Form type
3
Filing time
22 Aug 2023, 16:15:16 UTC
Next filing
24 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNGX Common Stock 194,174 11 Aug 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were acquired by the Reporting Person pursuant to a securities purchase agreement in a private placement offering of shares of the Issuer's common stock, which offering closed on August 11, 2023.
F2 These shares are directly held by Third Rock Ventures VI, L.P. ("TRV VI"). The general partner of TRV VI is Third Rock Ventures GP VI, L.P. ("TRV GP VI"). The general partner of TRV GP VI is TRV GP VI, LLC ("TRV GP VI LLC"). Each of TRV GP VI and TRV GP VI LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Remarks:

Reid Huber, a partner at Third Rock Ventures, LLC, has been deputized to represent the Reporting Persons (and other funds affiliated with Third Rock Ventures, LLC that hold shares of the Issuer's stock) on the board of directors of the Issuer. By virtue of Mr. Huber's representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Person may be deemed directors by deputization of the Issuer.